As the NHS battles to suppress the coronavirus, communities across Britain have been adjusting to a new reality. Meanwhile, pharma has taken on the task of managing, sustaining and boosting its international supply chains. The industry is, so far,
The rule book when it comes to delivering innovative clinical research is now being rewritten on a monthly basis. There is now a far greater expectation for medical mysteries and biological riddles to be solved in record times. Needless to say, UK
Amid the chaos of Brexit, pioneering clinical research continues defiantly, plotting its way through the complexity of disease and providing patients with the currencies of hope, transformation and reinvention. - Magazine Article - PharmaTimes
The future of AI in pharma and wider healthcare is unfolding right now – never has the crystal ball of science found itself so resolutely in the present. If we dare to glance at the horizon, however, we will see the dreamscape of an
An exciting, futuristic chapter for clinical trials has opened in which participant engagementwill flourish, expansive data will navigate the maze of disease and digital technology will take pharma and patients to previously unexplored dimensions.
It’s the start of a glorious new decade for pharma. As the advances in medtech, gadgets and innovation jump into hyperspace, a completely rebooted pharmaverse awaits us. The new era offers the chance to inspire and define, while navigating it